Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.
Company profile
Ticker
VAR
Exchange
Website
CEO
Dow Wilson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical • Fonar ...
Former names
VARIAN ASSOCIATES INC /DE/
SEC CIK
Corporate docs
Subsidiaries
CyberHeart, Inc. • D3 Oncology Inc. • Endocare, Inc. • Mansfield Insurance Company • Mobius Medical Systems Holdings, LLC • Mobius Medical Systems, LP • Page Mill Corporation • Varian BioSynergy, Inc. • Varian Medical Systems Africa Holdings, Inc. • Varian Medical Systems Canada Holdings, Inc. ...
IRS number
942359345
VAR stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
26 Apr 21
25-NSE
Exchange delisting
15 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 21
8-K
Termination of a Material Definitive Agreement
15 Apr 21
8-K
Departure of Directors or Certain Officers
8 Apr 21
8-K
Departure of Directors or Certain Officers
8 Mar 21
8-K
Varian Announces CEO Succession Plan
2 Mar 21
Transcripts
VAR
Earnings call transcript
2020 Q2
4 May 20
VAR
Earnings call transcript
2020 Q1
30 Jan 20
VAR
Earnings call transcript
2019 Q4
23 Oct 19
VAR
Earnings call transcript
2019 Q3
24 Jul 19
VAR
Earnings call transcript
2019 Q2
24 Apr 19
VAR
Earnings call transcript
2019 Q1
23 Jan 19
VAR
Earnings call transcript
2018 Q4
23 Oct 18
VAR
Earnings call transcript
2018 Q3
25 Jul 18
VAR
Earnings call transcript
2018 Q2
25 Apr 18
VAR
Earnings call transcript
2018 Q1
24 Jan 18
Latest ownership filings
Financial summary
Quarter (USD) | Jan 21 | Oct 20 | Jul 20 | Apr 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Oct 20 | Sep 19 | Sep 18 | Sep 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|